Table 3.

Factors predictive for early progression in multivariate analyses (n = 194 patients)

	Odds ratio	95% CI	P
Current smoking	2.276	0.860–6.025	0.098
Performance status ≥ 2	1.843	0.947–3.584	0.072
Abdominal metastatic site	2.174	1.125–4.199	0.021
Nos-NSCLC	1.978	0.921–4.251	0.080

Logistic regression. Biomarkers and weight loss were not included in the model because of the amount of missing data. Age and time since diagnosis were not included because of their lack of clinical implication.